Retinopathy of prematurity in India - what can we learn from the polio legacy?

Autor:	Athikarisamy SE; Neonatal Directorate, Child Adolescent Health Service, Perth, Western Australia, Australia.; School of Medicine, University of Western Australia, Crawley, Western Australia, Australia., Vinekar A; Director, KIDROP, Narayana Nethralaya Eye Institute, Bangalore, India., Patole S; Neonatal Directorate, Child Adolescent Health Service, Perth, Western Australia, Australia.; School of Medicine, University of Western Australia, Crawley, Western Australia, Australia.
Jazyk:	angličtina
Zdroj:	The Lancet regional health. Southeast Asia [Lancet Reg Health Southeast Asia] 2023 May 10; Vol. 14, pp. 100210. Date of Electronic Publication: 2023 May 10 (Print Publication: 2023).
DOI:	10.1016/j.lansea.2023.100210
Abstrakt:	Retinopathy of prematurity (ROP) is a vasoproliferative disease of the preterm retina that has the potential to cause vision impairment and blindness. Timely screening and treatment are hence critical for infants at risk for ROP. Screening for ROP is challenging in India owing to the limited resources, a vast at-risk population and lack of awareness among paediatricians and the public. Addressing ROP in India requires a comprehensive approach involving multiple sectors, considering the magnitude of the problem and the expected increase in need for ROP services due to the increased survival of preterm infants following improvements in neonatal care. The success of the Global Polio Eradication Initiative (GPEI) offers valuable lessons for improving ROP services in developing nations by applying its strategies. An approach for primary and secondary prevention of ROP is proposed, and the current challenges and a neonatal-led care model for ROP are discussed. Competing Interests: We declare no competing interests. (© 2023 The Author(s).)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu